Source link : https://www.newshealth.biz/health-news/europe-approves-exblifep-for-utis-and-pneumonia/
The European Medicines Agency (EMA) has recommended that the medicinal product cefepime-enmetazobactam (Exblifep) should be granted a marketing authorization for treating adults with urinary tract infections (UTIs) and hospital-acquired pneumonia. Exblifep is a combination of cefepime, a fourth-generation cephalosporin, and enmetazobactam, a novel extended-spectrum beta-lactamase inhibitor. Cefepime exerts bactericidal activity by inhibiting peptidoglycan cell wall […]
Author : News Health
Publish date : 2024-01-26 16:20:58
Copyright for syndicated content belongs to the linked Source.